SCHEMBL545425

SCHEMBL545425

CCCCCCCCCCCCCCCCCC(=O)OCCCO

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.77
DNM1 Q05193 1/20 0.62
NAAA Q02083 1/20 0.59
PRSS1 P07477 1/20 0.58
PRSS2 P07478 1/20 0.58
PRSS3 P35030 1/20 0.58
PAM P19021 2/20 0.58
LMNA P02545 2/20 0.56
KDM4E B2RXH2 1/20 0.56
DUSP3 P51452 1/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
HTR2C P28335 1/20 0.56
TSHR P16473 1/20 0.55
MAPT P10636 1/20 0.55
MGLL Q99685 1/20 0.54
ALDH1A1 P00352 1/20 0.53
PRKCA P17252 1/20 0.53
PRKCE Q02156 1/20 0.53
PRKCQ Q04759 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2532999 1.00 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL2800226 1.00 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL3502015 1.00 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL770067 1.00 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL769295 1.00 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL20348890 1.00 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL2040630 1.00 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL5608051 0.98 DGKA (0.74) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL28266709 0.98 DGKA (0.74) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL16013466 0.98 DGKA (0.74) DGKADNM1NAAAPRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260115155-A1 STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN CHORDA PHARMA INC (US) 2026-04-30 US claimed
US-12291637-B2 Acidic bonding compositions and methods for restoring and color toning lightened hair L'OREAL (FR) 2025-05-06 US claimed
CN-119606779-A External cream for directional delivery of tranexamic acid to epidermis layer and preparation method thereof 上海力芯联创生物医药科技有限公司 2025-03-14 CN claimed
US-20240124708-A1 ACIDIC BONDING COMPOSITIONS AND METHODS FOR RESTORING AND COLOR TONING LIGHTENED HAIR L'OREAL (FR) 2024-04-18 US claimed
US-20210230363-A1 DERIVATIVES OF 1,3-PROPANEDIOL VANTAGE SPECIALTY CHEMICALS INC (US) 2021-07-29 US claimed
US-8425784-B2 Ozonolysis reactions in liquid CO2 and CO2-expanded solvents UNIVERSITY OF KANSAS (US) 2013-04-23 US claimed
US-8202961-B2 Alkylphenol for adjusting the molecular weight, and polycarbonate compositions having improved properties BAYER MATERIALSCIENCE AG (DE) 2012-06-19 US claimed
US-20100317776-A1 ALKYLPHENOL FOR ADJUSTING THE MOLECULAR WEIGHT, AND POLYCARBONATE COMPOSITIONS HAVING IMPROVED PROPERTIES BAYER MATERIALSCIENCE AG (DE) 2010-12-16 US claimed
EP-4734930-A1 MIXED COMPOSITIONS COMPRISING 1,3-PROPANEDIOL ESTERS FOR COSMETIC FORMULATIONS IN PARTICULAR Evonik Operations GmbH (DE) 2026-05-06 EP disclosed
US-20260115155-A1 STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN CHORDA PHARMA INC (US) 2026-04-30 US disclosed
EP-4733295-A1 STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN Chorda Pharma, Inc. (US) 2026-04-29 EP disclosed
US-12599546-B2 Hair treatment compositions, kits thereof, and methods thereof L'OREAL (FR) 2026-04-14 US disclosed
US-20260069521-A1 COSMETIC COMPOSITION FOR IMPROVED PENETRATION L'OREAL (FR) 2026-03-12 US disclosed
US-12552743-B2 Oligonucleotide compositions and methods of use thereof WAVE LIFE SCIENCES LTD. (SG) 2026-02-17 US disclosed
CN-1316901-A The use of fumaric acid derivatives in transplant medicine FUMAPHARM AG (CH) 2001-10-10 CN disclosed
CN-1257426-A Use of fumaric acid derivatives FUMAPHARM AG (CH) 2000-06-21 CN disclosed
WO-1994018830-A1 ORGANIC PEROXIDE COMPOSITIONS AND PROCESS THEREFOR AZTEC PEROXIDES, INC. (US) 1994-09-01 WO disclosed
CN-1088930-A Stable organotin compound and its production and application TAI AN GENERAL FINE CHEMICAL P (CN) 1994-07-06 CN disclosed
US-5276202-A Stabilization of peroxides with phlegmatization agent with polyesters for plasticizing PHILLIPS PETROLEUM COMPANY (US) 1994-01-04 US disclosed
US-4364743-A ESTER AND MIDDLE OIL ERNER WILLIAM E 1982-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552743-B2 Oligonucleotide compositions and methods of use thereof NSUN3, NSUN2, SNRPA1 DGKA 3514/4885DNM1 2007/4885NAAA 4728/4885
US-20210230363-A1 DERIVATIVES OF 1,3-PROPANEDIOL BBOX1, PGD, DDT DGKA 272/4885DNM1 1954/4885NAAA 3114/4885
US-12291637-B2 Acidic bonding compositions and methods for restoring and color toning lightened hair SHH, TIPRL, SMURF1 DGKA 4198/4885DNM1 2277/4885NAAA 520/4885
US-12599546-B2 Hair treatment compositions, kits thereof, and methods thereof EBP, FHIT, BRDT DGKA 153/4885DNM1 2400/4885NAAA 1317/4885
US-20100317776-A1 ALKYLPHENOL FOR ADJUSTING THE MOLECULAR WEIGHT, AND POLYCARBONATE COMPOSITIONS HAVING IMPROVED PROPERTIES TUFM, UFM1, WASF2 DGKA 3869/4885DNM1 4476/4885NAAA 3840/4885
US-20240124708-A1 ACIDIC BONDING COMPOSITIONS AND METHODS FOR RESTORING AND COLOR TONING LIGHTENED HAIR SHH, TIPRL, SMURF1 DGKA 4198/4885DNM1 2277/4885NAAA 520/4885
US-20260069521-A1 COSMETIC COMPOSITION FOR IMPROVED PENETRATION CUTA, SLC14A1, DSG1 DGKA 2790/4885DNM1 4824/4885NAAA 965/4885
US-20260115155-A1 STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN TRPV1, SPTLC3, FFAR3 DGKA 3013/4885DNM1 3461/4885NAAA 2890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.